Cargando…

Prognostic impact of follow‐up serum albumin after acute myocardial infarction

AIMS: Previous studies have suggested that low serum albumin (LSA) at admission for acute myocardial infarction (AMI) is associated with adverse in‐hospital outcomes. The aim of this study was to investigate whether LSA in the remote phase after AMI is prognostic for long‐term outcomes. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshioka, Goro, Tanaka, Atsushi, Nishihira, Kensaku, Natsuaki, Masahiro, Kawaguchi, Atsushi, Watanabe, Nozomi, Shibata, Yoshisato, Node, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712885/ https://www.ncbi.nlm.nih.gov/pubmed/34612008 http://dx.doi.org/10.1002/ehf2.13640

Ejemplares similares

Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction
por: Yoshioka, Goro, et al.
Publicado: (2022)

Prognostic Impact of Serum Albumin for Developing Heart Failure Remotely after Acute Myocardial Infarction
por: Yoshioka, Goro, et al.
Publicado: (2020)

A Novel Predictive Model for In-Hospital Mortality Based on a Combination of Multiple Blood Variables in Patients with ST-Segment-Elevation Myocardial Infarction
por: Goriki, Yuhei, et al.
Publicado: (2020)

Development of a Laboratory Risk-Score Model to Predict One-Year Mortality in Acute Myocardial Infarction Survivors
por: Goriki, Yuhei, et al.
Publicado: (2022)

A Novel Prediction Model of Acute Kidney Injury Based on Combined Blood Variables in STEMI
por: Goriki, Yuhei, et al.
Publicado: (2021)

ST-Elevation Myocardial Infarction With Cardiogenic Shock and Severe Acute Ischemic Mitral Regurgitation Rescued by Primary Coronary Intervention Under Hemodynamic Support With Impella
por: Koiwaya, Hiroshi, et al.
Publicado: (2021)

Lotus Root-Like Appearance of a Lipid-Rich Plaque in a Patient With Acute Myocardial Infarction　― Findings From Near-Infrared Spectroscopy and Optical Coherence Tomography ―
por: Nishihira, Kensaku, et al.
Publicado: (2021)

Impact of 1 month of intensive lipid-lowering therapy on plaque composition evaluated using near-infrared spectroscopy
por: Nishihira, Kensaku, et al.
Publicado: (2021)

Ruptured lipid-rich plaque in a saphenous vein graft causing no-reflow phenomenon: insights from near-infrared spectroscopy, optical coherence tomography, and histopathological analysis
por: Nishihira, Kensaku, et al.
Publicado: (2021)

Visualization of a Rapidly Progressing Lipid-Rich Plaque Causing No-Reflow Phenomenon During Percutaneous Coronary Intervention　― Insights From Near-Infrared Spectroscopy and Histopathology ―
por: Honda, Yasuhiro, et al.
Publicado: (2019)

Chlamydia pneumoniae is Prevalent in Symptomatic Coronary Atherosclerotic Plaque Samples Obtained From Directional Coronary Atherectomy, but its Quantity is Not Associated With Plaque Instability: An Immunohistochemical and Molecular Study
por: Otani, Tomoyuki, et al.
Publicado: (2022)

Outcomes of Elderly Patients With Acute Myocardial Infarction and Heart Failure Who Undergo Percutaneous Coronary Intervention
por: Nishihira, Kensaku, et al.
Publicado: (2022)

Successful sealing of a coronary aneurysm by novel, second-generation, covered stent implantation: first report of optical coherence tomography and coronary angioscopy evaluation
por: Koiwaya, Hiroshi, et al.
Publicado: (2021)

Pathological findings of a distal embolus during laser atherectomy for in-stent occlusion of the superficial femoral artery
por: Ogata, Kenji, et al.
Publicado: (2023)

Left main coronary artery embolism caused by BioGlue surgical adhesive after type A acute aortic dissection repair: intracoronary imaging and histopathological analysis
por: Yamamoto, Keisuke, et al.
Publicado: (2023)

Takotsubo Syndrome After Additional Right Ventricular Lead Insertion in a Pacemaker User
por: Yoshioka, Goro, et al.
Publicado: (2022)

Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites
por: Yamashita, Atsushi, et al.
Publicado: (2021)

Septic pulmonary embolism caused by infected adherent fibrous tissue after percutaneous lead extraction
por: Tsumagari, Yasuaki, et al.
Publicado: (2023)

De-Escalation Therapy After PCI in ACS Patients With Chronic Kidney Disease
por: Natsuaki, Masahiro, et al.
Publicado: (2023)

N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome
por: Sasaki, Shoh, et al.
Publicado: (2022)

A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction
por: Kitsuka, Takahiro, et al.
Publicado: (2022)

Author Correction: A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction
por: Kitsuka, Takahiro, et al.
Publicado: (2022)

Prediction of Stroke After Cardiac Catheterization: No Reason, No Stroke
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials
por: Tanaka, Atsushi, et al.
Publicado: (2019)

Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
por: Tanaka, Atsushi, et al.
Publicado: (2020)

How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition?
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Crosstalk between the liver and heart: revisited for prevention and treatment
por: Tanaka, Atsushi, et al.
Publicado: (2020)

The Emerging and Promising Role of Care for Cardiometabolic Syndrome in Prostate Cancer
por: Tanaka, Atsushi, et al.
Publicado: (2019)

Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors
por: Tanaka, Atsushi, et al.
Publicado: (2021)

In‐hospital therapy for worsening heart failure: black box or sweet spot?
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19
por: Tanaka, Atsushi, et al.
Publicado: (2022)

So‐far overlooked HFpEF patients with normal natriuretic peptide level need more evidence
por: Tanaka, Atsushi, et al.
Publicado: (2022)

What More Can Be Delivered to Future Patients with Coronary Syndromes?
por: Tanaka, Atsushi, et al.
Publicado: (2022)

Efficacy of Cardiac Computed Tomography for Obstructive Mechanical Valve Thrombosis Under Venoarterial Extracorporeal Membrane Oxygenation
por: Chen, Wenhann, et al.
Publicado: (2022)

Vascular functional tests and preemptive medicine
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists
por: Sawami, Kosuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0lnuj5ldh2s2h0ldkhkjudqimn